{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:53:24Z","timestamp":1787018004624,"version":"build-2736575974"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[1999,1]]},"abstract":"<jats:p>\n                    <jats:italic>Abstract<\/jats:italic>\n                    \u2014Our objective was to compare cardiovascular event rates in patients with stable angina receiving nifedipine as monotherapy or combination therapy and in active drug controls. A MEDLARS search of published articles from 1966 to 1995 in English, French, German, Italian, or Spanish, supplemented by a manual search of bibliographies, identified 60 randomized controlled trials that met protocol criteria. Blinded articles were extracted by 2 physicians. The pooled risks of death, withdrawal, and cardiovascular event were computed and expressed as odds ratios (ORs) for all nifedipine formulations and relative to same study control drug regimens. Thirty cardiovascular events were reported in 2635 nifedipine exposures (1.14%) and 19 events in 2655 other active drug exposures (0.72%). Unadjusted ORs for nifedipine versus controls were 1.40 (95% CI, 0.56 to 3.49) for major events (death, nonfatal myocardial infarction, stroke, revascularization procedure), 1.75 (95% CI, 0.83 to 3.67) for increased angina, and 1.61 (95% CI, 0.91 to 2.87) for all events (major events plus increased angina). Episodes of increased angina were more frequent on immediate-release nifedipine (OR, 4.19 [95% CI, 1.41 to 12.49]) and on nifedipine monotherapy (OR, 2.61 [95% CI, 1.30 to 5.26]). The OR for immediate-release nifedipine was significantly higher than that for sustained-release\/extended-release nifedipine (\n                    <jats:italic>P<\/jats:italic>\n                    =0.001), and the OR for nifedipine monotherapy was higher than that for nifedipine combination therapy (\n                    <jats:italic>P<\/jats:italic>\n                    =0.03). Increased risks of cardiovascular events in patients with stable angina on nifedipine were due primarily to more episodes of increased angina, confined to the immediate-release formulation and to nifedipine monotherapy.\n                  <\/jats:p>","DOI":"10.1161\/01.hyp.33.1.24","type":"journal-article","created":{"date-parts":[[2012,6,11]],"date-time":"2012-06-11T20:53:46Z","timestamp":1339448026000},"page":"24-31","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":32,"title":["Safety of Nifedipine in Angina Pectoris"],"prefix":"10.1161","volume":"33","author":[{"given":"William B.","family":"Stason","sequence":"first","affiliation":[{"name":"From the Harvard School of Public Health (W.B.S.); Tufts University\/New England Medical Center (C.H.S., D.C.); MetaWorks, Inc (W.B.S., D.N., G.W.W., J-F.C., D.L., S.D.R., T.C.C.); and Tufts University (T.C.C.), Boston, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Schmid","sequence":"additional","affiliation":[{"name":"From the Harvard School of Public Health (W.B.S.); Tufts University\/New England Medical Center (C.H.S., D.C.); MetaWorks, Inc (W.B.S., D.N., G.W.W., J-F.C., D.L., S.D.R., T.C.C.); and Tufts University (T.C.C.), Boston, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Niedzwiecki","sequence":"additional","affiliation":[{"name":"From the Harvard School of Public Health (W.B.S.); Tufts University\/New England Medical Center (C.H.S., D.C.); MetaWorks, Inc (W.B.S., D.N., G.W.W., J-F.C., D.L., S.D.R., T.C.C.); and Tufts University (T.C.C.), Boston, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory W.","family":"Whiting","sequence":"additional","affiliation":[{"name":"From the Harvard School of Public Health (W.B.S.); Tufts University\/New England Medical Center (C.H.S., D.C.); MetaWorks, Inc (W.B.S., D.N., G.W.W., J-F.C., D.L., S.D.R., T.C.C.); and Tufts University (T.C.C.), Boston, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Caubet","sequence":"additional","affiliation":[{"name":"From the Harvard School of Public Health (W.B.S.); Tufts University\/New England Medical Center (C.H.S., D.C.); MetaWorks, Inc (W.B.S., D.N., G.W.W., J-F.C., D.L., S.D.R., T.C.C.); and Tufts University (T.C.C.), Boston, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Cory","sequence":"additional","affiliation":[{"name":"From the Harvard School of Public Health (W.B.S.); Tufts University\/New England Medical Center (C.H.S., D.C.); MetaWorks, Inc (W.B.S., D.N., G.W.W., J-F.C., D.L., S.D.R., T.C.C.); and Tufts University (T.C.C.), Boston, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Luo","sequence":"additional","affiliation":[{"name":"From the Harvard School of Public Health (W.B.S.); Tufts University\/New England Medical Center (C.H.S., D.C.); MetaWorks, Inc (W.B.S., D.N., G.W.W., J-F.C., D.L., S.D.R., T.C.C.); and Tufts University (T.C.C.), Boston, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan D.","family":"Ross","sequence":"additional","affiliation":[{"name":"From the Harvard School of Public Health (W.B.S.); Tufts University\/New England Medical Center (C.H.S., D.C.); MetaWorks, Inc (W.B.S., D.N., G.W.W., J-F.C., D.L., S.D.R., T.C.C.); and Tufts University (T.C.C.), Boston, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Chalmers","sequence":"additional","affiliation":[{"name":"From the Harvard School of Public Health (W.B.S.); Tufts University\/New England Medical Center (C.H.S., D.C.); MetaWorks, Inc (W.B.S., D.N., G.W.W., J-F.C., D.L., S.D.R., T.C.C.); and Tufts University (T.C.C.), Boston, Mass."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.92.5.1326"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530080036038"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.3109\/08037059309077541"},{"key":"e_1_3_2_4_2","first-page":"287","volume":"3","year":"1991","unstructured":"Amery A, Birkenhager W, Bulpitt CJ, Clement D, De Leeuw P, Dollery CT, Fagard R, Fletcher A, Forette F, Leonetti G. Syst-Eur: A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol and organization. Aging (Milano). 1991;3:287\u2013302.","journal-title":"Aging (Milano)"},{"key":"e_1_3_2_5_2","first-page":"314","volume":"2","year":"1992","unstructured":"The NORDIL Group. The Nordic Diltiazem Study (NORDIL): a prospective intervention trial of calcium antagonist therapy in hypertension. Blood Press. 1992;2:314\u2013321.","journal-title":"Blood Press"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-7061(96)00037-4"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","unstructured":"Stason WB Schmid CH Niedzwiecki D Whiting GW Luo D Ross SD Chalmers TC. Safety of nifedipine in patients with hypertension. Hypertension. 1997;30(pt 1):7\u201314.","DOI":"10.1161\/01.HYP.30.1.7"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198702193160806"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(81)90056-8"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(95)00134-4"},{"key":"e_1_3_2_11_2","unstructured":"SAS Institute. SAS\/STAT Users Guide. Cary NC: SAS Institute; 1989:1071\u20131126."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-0620(85)80003-7"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","unstructured":"Hosmer DW Lemeshow S. Applied Logistic Regression. New York NY: John Wiley & Sons; 1989.","DOI":"10.2307\/2531779"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5273(89)90304-5"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91900-F"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1177\/030006058901700210"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90165-H"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00042-3"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(90)91312-T"},{"key":"e_1_3_2_21_2","first-page":"343","volume":"226","year":"1982","unstructured":"Bailey JS. The prophylaxis of angina pectoris in general practice: a placebo-controlled comparison of nifedipine and propranolol. Practitioner. 1982;226:343\u2013345.","journal-title":"Practitioner"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000174887"},{"key":"e_1_3_2_23_2","first-page":"1242","volume":"33","year":"1982","unstructured":"Bohm C, Christl HL, Wald G. Drug therapy of coronary heart disease: comparative effects of nifedipine and isosorbide dinitrate. Med Welt. 1982;33:1242\u20131244.","journal-title":"Med Welt"},{"key":"e_1_3_2_24_2","first-page":"10","volume":"83","year":"1987","unstructured":"Chung M, Reitberg DP, Gaffney M, Singleton W. Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system: a controlled-release formulation of nifedipine. Am J Med. 1987;83:10\u201314.","journal-title":"Am J Med"},{"key":"e_1_3_2_25_2","first-page":"59","volume":"10","year":"1979","unstructured":"Cocco G, Strozzi C, Chu D, Amrein R, Castagnoli E. Therapeutic effects of pindolol and nifedipine in patients with stable angina pectoris and asymptomatic resting ischemia. Eur J Cardiol. 1979;10:59\u201369.","journal-title":"Eur J Cardiol"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a062430"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","unstructured":"Dalla-Volta S Maraglino G Della-Valentina P Viena P Desideri A. Comparison of trimetazidine with nifedipine in effort angina: a double-blind crossover study. Cardiovasc Drugs Ther. 1990;4(suppl 4):853\u2013859.","DOI":"10.1007\/BF00051292"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.46.5.508"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(91)90880-I"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5273(84)90293-6"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/14.4.534"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(88)90147-0"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960020306"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/14.10.1369"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a060156"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(85)90563-6"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.77.4.3280158"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(82)90527-0"},{"key":"e_1_3_2_39_2","first-page":"2081","volume":"11","year":"1981","unstructured":"Gruppillo P, Battaglia R, Masoni C, Maistrello I, Masoni A. Therapeutical comparison between atenolol and nifedipine in effort angina (author\u2019s translation). G Ital Cardiol. 1981;11:2081\u20132087.","journal-title":"G Ital Cardiol"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.284.6323.1148"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90181-2"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90519-Q"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(85)90136-5"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(92)90499-D"},{"key":"e_1_3_2_45_2","first-page":"398","volume":"71","year":"1982","unstructured":"Klein W, Brandt D, Fluch N, Maurer E. Treatment of stable exercise angina with calcium blockers-a double-blind, placebo-controlled comparison of diltiazem and nifedipine [in German]. Z Kardiol. 1982;71:398\u2013405.","journal-title":"Z Kardiol"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1984.105"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1987.5"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(88)80026-3"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a060208"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(85)91205-6"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.281.6234.184"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199212000-00003"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(88)90542-5"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90433-L"},{"key":"e_1_3_2_55_2","first-page":"6","volume":"3","year":"1981","unstructured":"Pitcher D, Sowton E. Double-blind trial of nifedipine in angina patients with normal coronary arteries. Pharmatherapeutica. 1981;3:6\u201313.","journal-title":"Pharmatherapeutica"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(87)80397-2"},{"key":"e_1_3_2_57_2","first-page":"2097","volume":"11","year":"1981","unstructured":"Regoli F, Giusti C. Dilazep vs. nifedipine in patients with stable effort angina: a double blind randomized study (author\u2019s translation). G Ital Cardiol. 1981;11:2097\u20132104.","journal-title":"G Ital Cardiol"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5273(88)90236-7"},{"key":"e_1_3_2_59_2","first-page":"525","volume":"81","year":"1992","unstructured":"Rettig GF, Jakob M, Koch HP. The anti-ischemic effect of gallopamil-retard in comparison with nifedipine-retard in stable angina pectoris. Z Kardiol. 1992;81:525\u2013530.","journal-title":"Z Kardiol"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90647-4"},{"key":"e_1_3_2_61_2","unstructured":"Ruzicka M Leenen FHH. Relevance of intermittent increases in sympathetic activity for adverse outcome on short-acting calcium antagonists. In: Laragh JH Brenner BM eds. Hypertension: Pathophysiology Diagnosis and Management. New York NY: Raven Press Ltd; 1995:2815\u20132825."},{"key":"e_1_3_2_62_2","first-page":"587","volume":"8","year":"1978","unstructured":"Scardi S, Borgioni L, Alberti E, Palmieri M, Passarelli A, Ruggeri G, Zappala A, Baroni F, Camerini F. Controlled clinical trial of 5 antianginal treatments. G Ital Cardiol. 1978;8:587\u2013600.","journal-title":"G Ital Cardiol"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a060881"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90454-2"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(83)80119-2"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(93)90901-N"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.82.6.2122926"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(88)90146-9"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(82)91221-8"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.77.6.3286041"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1981.tb01205.x"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(86)90604-1"},{"key":"e_1_3_2_73_2","first-page":"60","volume":"12","year":"1991","unstructured":"van der Does R, Eberhardt R, Derr I, Ehmer B, Rudorf J, Uberbacher HJ. Treatment of chronic stable angina with carvedilol in comparison with nifedipine s.r. Eur Heart J. 1991;12:60\u201364.","journal-title":"Eur Heart J"},{"key":"e_1_3_2_74_2","first-page":"71","volume":"60","year":"1990","unstructured":"Villalpando Gutierrez J, Navarro Robles J, Necoechea Alva JC, Aceves Miramontes C, Parcero Valdez JJ. A comparative clinical study of calcium blockers, gallopamil and nifedipine, in the treatment of stable chest angina. Arch Inst Cardiol Mex. 1990;60:71\u201377.","journal-title":"Arch Inst Cardiol Mex"},{"key":"e_1_3_2_75_2","first-page":"104","volume":"17","year":"1996","unstructured":"Dargie HJ, Ford I, Fox KM, on behalf of the TIBET Study Group. Total Ischaemic Burden European Trial (TIBET): effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. Eur Heart J. 1996;17:104\u2013112.","journal-title":"Eur Heart J"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)00345-Q"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(94)90721-8"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90310-X"},{"key":"e_1_3_2_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(85)90361-3"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.33.1.24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T13:34:59Z","timestamp":1715520899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.33.1.24"}},"subtitle":["A Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["10.1161\/01.HYP.33.1.24"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.33.1.24","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,1]]},"assertion":[{"value":"1998-06-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-09-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}